DaVita HealthCare Partners Inc. provides kidney dialysis services for
patients suffering from chronic kidney failure or end stage renal
disease. It operates kidney dialysis centers and provides related lab
services primarily in outpatient dialysis centers and in contracted
hospitals. The company offers outpatient, hospital inpatient, and
home-based hemodialysis services; owns clinical laboratories that
provide routine laboratory tests for dialysis and other
physician-prescribed laboratory tests for ESRD patients; and management
and administrative services to outpatient dialysis centers. In addition,
the company offers DaVita Rx, a pharmacy that provides oral medications
to patients with ESRD; disease management services; vascular access
services; ESRD clinical research programs; physician services; and
direct primary care services. As of March 31, 2014, it operated 2,173
outpatient dialysis centers, including 2,098 centers located in the
United States; and 75 centers located in 10 countries outside the United
States.
To review DaVita’s stock, please take a look at the 1-year chart of
DVA (DaVita Healthcare Partners, Inc.) below with my added notations:
DVA has been trading sideways for the last 2 months. Over that period
of time the stock has formed a decent resistance level at $70 (red). In
addition, the stock has also created a level of support at $67 (blue).
At some point the stock will have to break one of the two levels the
rectangle pattern has created.
The Tale of the Tape: DVA has clear levels of
support ($70) and resistance ($67). The possible long positions on the
stock would be either on a pullback to $67, or on a breakout above $70.
The ideal short opportunity would be on a break below $67.
Please share this article
Click Here to Listen to the Audio